Outlook Therapeutics Inc
For the period ended Sep 30, 2024. Filed Dec 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Dec 27, 2024
OTLK$0.46+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 8. Consolidated Financial Statements and Supplementary Data
OUTLOOK THERAPEUTICS, INC.
ANNUAL REPORT ON FORM 10-K
INDEX TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS
| | |
|---|---|
| | Page |
| | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 185) | 103 |
| Consolidated Balance Sheets | 105 |
| Consolidated Statements of Operations | 106 |
| Consolidated Statements of Stockholders’ Equity (Deficit) | 107 |
| Consolidated Statements of Cash Flows | 108 |
| Notes to Consolidated Financial Statements | 109 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.